# Nuo Therapeutics, Inc.: Form 10-Q for the period ended Jun 30, 2016

- Company: [Nuo Therapeutics, Inc.](/companies/aurx.md) (CIK 1091596)
- Form: 10-Q
- Filed: 2016-10-24
- Accepted by EDGAR: Oct 21, 2016, 19:07 ET
- Period: 2016-06-30
- Accession: 0001144204-16-129031
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1091596/000114420416129031/v450052_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1091596/000114420416129031/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2016-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cash and equivalents | at 2016-06-30 | $6.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2016-06-30 | $8.1m | us-gaap:AssetsCurrent |
| Total assets | at 2016-06-30 | $19.6m | us-gaap:Assets |
| Current liabilities | at 2016-06-30 | $2.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2016-06-30 | $2.8m | us-gaap:Liabilities |
| Shareholders' equity | at 2016-06-30 | $16.8m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1091596/000114420416129031/v450052_10q.htm

Filed Oct 24, 2016.
Source: SEC EDGAR, the filing index for accession 0001144204-16-129031. Last ingested by Listed: Nov 14, 2026, 23:44 ET. No prices; not investment advice.
